Iterum Therapeutics Statistics
Total Valuation
ITRMF has a market cap or net worth of 2.38 million. The enterprise value is 25.11 million.
| Market Cap | 2.38M |
| Enterprise Value | 25.11M |
Important Dates
The last earnings date was Monday, May 18, 2026.
| Earnings Date | May 18, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ITRMF has 52.84 million shares outstanding. The number of shares has increased by 124.80% in one year.
| Current Share Class | 52.84M |
| Shares Outstanding | 52.84M |
| Shares Change (YoY) | +124.80% |
| Shares Change (QoQ) | +14.69% |
| Owned by Insiders (%) | 0.79% |
| Owned by Institutions (%) | 5.39% |
| Float | 52.42M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.10 |
| PB Ratio | -0.32 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.93 |
| EV / Sales | 64.39 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -1.29 |
Financial Position
The company has a current ratio of 2.13
| Current Ratio | 2.13 |
| Quick Ratio | 1.80 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.73 |
| Interest Coverage | -9.53 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -53.28% |
| Return on Invested Capital (ROIC) | -133.17% |
| Return on Capital Employed (ROCE) | -79.16% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 43,333 |
| Profits Per Employee | -3.00M |
| Employee Count | 9 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ITRMF has paid 276,000 in taxes.
| Income Tax | 276,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -95.44% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -95.44% |
| 50-Day Moving Average | 0.07 |
| 200-Day Moving Average | 0.40 |
| Relative Strength Index (RSI) | 47.75 |
| Average Volume (20 Days) | 184,466 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.08 |
Income Statement
In the last 12 months, ITRMF had revenue of 390,000 and -26.96 million in losses. Loss per share was -0.74.
| Revenue | 390,000 |
| Gross Profit | 116,000 |
| Operating Income | -20.64M |
| Pretax Income | -26.69M |
| Net Income | -26.96M |
| EBITDA | -19.32M |
| EBIT | -20.64M |
| Loss Per Share | -0.74 |
Balance Sheet
The company has 11.00 million in cash and 33.74 million in debt, with a net cash position of -22.73 million or -0.43 per share.
| Cash & Cash Equivalents | 11.00M |
| Total Debt | 33.74M |
| Net Cash | -22.73M |
| Net Cash Per Share | -0.43 |
| Equity (Book Value) | -7.38M |
| Book Value Per Share | -0.15 |
| Working Capital | 7.30M |
Cash Flow
In the last 12 months, operating cash flow was -19.51 million and capital expenditures -14,000, giving a free cash flow of -19.53 million.
| Operating Cash Flow | -19.51M |
| Capital Expenditures | -14,000 |
| Depreciation & Amortization | 1.32M |
| Net Borrowing | -14.75M |
| Free Cash Flow | -19.53M |
| FCF Per Share | -0.37 |
Margins
| Gross Margin | 29.74% |
| Operating Margin | -5,292.31% |
| Pretax Margin | -6,842.31% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ITRMF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -124.80% |
| Shareholder Yield | -124.80% |
| Earnings Yield | -1,133.97% |
| FCF Yield | -821.34% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 18, 2022. It was a reverse split with a ratio of 0.0666667.
| Last Split Date | Aug 18, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.0666667 |
Scores
ITRMF has an Altman Z-Score of -23.03 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -23.03 |
| Piotroski F-Score | 2 |